Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.6B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$963M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$738M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$237M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$905M |
| 2 |
Microsoft
MSFT
|
+$735M |
| 3 |
iShares MBS ETF
MBB
|
+$609M |
| 4 |
Linde
LIN
|
+$517M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$488M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.26% |
| 2 | Healthcare | 5.03% |
| 3 | Financials | 4.65% |
| 4 | Communication Services | 3.81% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUY
3326
CALL
DELISTED
Yamana Gold, Inc.
AUY
| $646K | ﹤0.01% |
234,900
+6,500
| +3% | +$24.5K |
|
3327
PUT
Ally Financial
ALLY
$13.5B
| $645K | ﹤0.01% |
44,700
+36,100
| +420% | +$948K |
|
3328
Amplify Alternative Harvest ETF
MJ
$103M
| $644K | ﹤0.01% |
+4,710
| New | +$836K |
|
3329
CALL
Yum! Brands
YUM
$41.4B
| $644K | ﹤0.01% |
9,400
-13,500
| -59% | -$1.26M |
|
|
BNY
3330
CALL
Bank of New York Mellon
BNY
$108B
| $643K | ﹤0.01% |
19,100
+4,700
| +33% | +$197K |
|
3331
Provident Financial Services
PFS
$3.24B
| $643K | ﹤0.01% |
49,948
-42,159
| -46% | -$856K |
|
3332
Amphastar Pharmaceuticals
AMPH
$872M
| $642K | ﹤0.01% |
43,275
-11,686
| -21% | -$203K |
|
|
TPTX
3333
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $641K | ﹤0.01% |
14,379
-13,916
| -49% | -$739K |
|
3334
PUT
National Beverage
FIZZ
$2.97B
| $640K | ﹤0.01% |
30,000
-200
| -0.7% | -$4.37K |
|
|
CTRA
3335
CALL
DELISTED
Coterra Energy
CTRA
| $639K | ﹤0.01% |
37,200
+36,800
| +9,200% | +$582K |
|
|
FARO
3336
DELISTED
Faro Technologies
FARO
| $639K | ﹤0.01% |
14,332
-11,563
| -45% | -$600K |
|
3337
CALL
MPLX
MPLX
$60.8B
| $639K | ﹤0.01% |
55,000
-50,400
| -48% | -$1.03M |
|
3338
United Parks & Resorts
PRKS
$2.08B
| $637K | ﹤0.01% |
57,807
-59,206
| -51% | -$1.62M |
|
|
IPG
3339
PUT
DELISTED
Interpublic Group of Companies
IPG
| $636K | ﹤0.01% |
39,300
+16,000
| +69% | +$338K |
|
|
CLVS
3340
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $636K | ﹤0.01% |
100,000
-53,400
| -35% | -$428K |
|
|
PDCO
3341
DELISTED
Patterson Companies, Inc.
PDCO
| $635K | ﹤0.01% |
41,557
-130,562
| -76% | -$2.82M |
|
|
RAVN
3342
DELISTED
Raven Industries Inc
RAVN
| $635K | ﹤0.01% |
29,998
-23,761
| -44% | -$696K |
|
|
ALEX
3343
DELISTED
Alexander & Baldwin
ALEX
| $634K | ﹤0.01% |
56,407
-17,612
| -24% | -$330K |
|
3344
Sonos
SONO
$1.83B
| $633K | ﹤0.01% |
74,533
-223,835
| -75% | -$2.76M |
|
3345
CALL
TripAdvisor
TRIP
$1.23B
| $633K | ﹤0.01% |
36,400
-116,600
| -76% | -$2.95M |
|
|
CLDT
3346
Chatham Lodging
CLDT
$602M
| $632K | ﹤0.01% |
106,264
+12,189
| +13% | +$171K |
|
3347
CALL
HF Sinclair
DINO
$14.8B
| $632K | ﹤0.01% |
25,800
-268,000
| -91% | -$10M |
|
3348
Pediatrix Medical
MD
$2.15B
| $632K | ﹤0.01% |
54,233
-31,023
| -36% | -$640K |
|
3349
RB Global
RBA
$17.3B
| $632K | ﹤0.01% |
18,500
+994
| +6% | +$39.7K |
|
3350
Red Robin
RRGB
$154M
| $632K | ﹤0.01% |
74,247
+47,811
| +181% | +$1.25M |
|
Similar funds
Barclays's Q1 2020 Portfolio in Review
As of Q1 2020, Barclays held 6,792 positions worth $127B, down 30% from $180B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.2B in Q1 2020, closing 596 positions and reducing 3,808 holdings. Its most notable exit was iShares MBS ETF, an estimated $609M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $42.3M.
- Barclays's largest Q1 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 1,242,519 shares worth $42.3M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $5.6B increase.
- Barclays's biggest Q1 2020 reduction was Apple, cutting an estimated $905M.
- Barclays fully exited iShares MBS ETF in Q1 2020, selling an estimated $609M.
- Barclays's ten largest holdings make up 34% of its $127B portfolio in Q1 2020.
- Barclays opened 279 new positions and closed 596 in Q1 2020.
- Barclays's portfolio value fell 30% quarter-over-quarter to $127B.
Based on Barclays's 13F filing for Q1 2020, filed 13 May 2020.